InSite Health, Inc. — Form D
InSite Health, Inc. of MARLTON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-21. The offering totals $2.9M, of which $2.9M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-02-21
- Form: D
- Accession: 0002012080-24-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.9M
- Amount sold: $2.9M
- Investors: 21
- Date of first sale: 2022-05-27
- Revenue range: Decline to Disclose
- SEC file number: 021-505685
Issuer
- Name: InSite Health, Inc.
- CIK: 0002012080
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: FIVE GREENTREE CENTER, 525 ROUTE 73, MARLTON, NJ, 08053
- Phone: 833-494-6724
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Christopher Gaeta | Director | Marlton, NJ |
| Mark Gaeta | Director | Marlton, NJ |
| Stephen Klasko | Director | Marlton, NJ |
| Andrew Zalasin | Director | Marlton, NJ |
| Christopher Gaeta | Executive Officer | Marlton, NJ |
More